Decoy Therapeutics Inc(DCOY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DCOY Decoy Therapeutics Inc

盘前交易 06-22 06:53:00 EDT

6.07

+0.12

+2.02%

最高6.20	最低6.07	成交量6,115
今开6.09	昨收5.95	日振幅2.18%
总市值322.93万	流通市值320.75万	总股本53.20万
成交额3.77万	换手率1.16%	流通股本52.84万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DCOY","market":"US","secType":"STK","nameCN":"Decoy Therapeutics Inc","latestPrice":6.07,"timestamp":1781812800000,"preClose":5.95,"halted":0,"volume":6115,"delay":0,"changeRate":0.020168067226890775,"floatShares":528425,"shares":532016,"eps":-57.119957,"marketStatus":"盘前交易","change":0.12,"latestTime":"06-22 06:53:00 EDT","open":6.09,"high":6.2,"low":6.07,"amount":37705.993185499996,"amplitude":0.021849,"askPrice":7,"askSize":10,"bidPrice":4.58,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-57.119957,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782135000000},"marketStatusCode":1,"adr":0,"listingDate":1422507600000,"exchange":"NASDAQ","adjPreClose":6.07,"postHourTrading":{"tag":"盘后","latestPrice":6.07,"preClose":6.07,"latestTime":"19:11 EDT","volume":21,"amount":128.1672,"timestamp":1781824305470,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6274099578695649},"requestUrl":"/m/hq/s/DCOY/tweets","defaultTab":"tweets","newsList":[{"id":"1110138438","title":"Decoy Therapeutics提名全球生物制药高管Patricia Gauthier参选董事会董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1110138438","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110138438?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:03","pubTimestamp":1780488220,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics Inc已提名全球生物制药领域的高管Patricia Gauthier参选公司董事会董事。这一提名旨在利用Gauthier在生物制药行业的丰富经验，为董事会的战略决策注入新的专业力量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157548363","title":"Decoy Therapeutics任命麻省理工学院化学教授Brad Pentelute为科学顾问委员会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=1157548363","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157548363?lang=zh_cn&edition=full","pubTime":"2026-05-26 20:15","pubTimestamp":1779797728,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics Inc宣布，已任命麻省理工学院化学系教授Brad Pentelute为其科学顾问委员会主席。这一任命旨在加强公司的科学战略与研发能力。Pentelute教授在化学生物学与蛋白质工程领域的深厚专长，将为Decoy Therapeutics在创新疗法开发方面提供关键指导。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182247272","title":"Decoy Therapeutics将出席虚拟投资者收市钟声活动 展望2026年业务前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1182247272","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182247272?lang=zh_cn&edition=full","pubTime":"2026-04-06 21:16","pubTimestamp":1775481376,"startTime":"0","endTime":"0","summary":"生物制药企业Decoy Therapeutics Inc（股票代码：DCOY）宣布将参与虚拟投资者收市钟声特别活动。本次线上会议将重点展示公司截至2026年的战略规划与业务发展蓝图，管理层将就研发管线进展、商业化布局及长期增长驱动因素进行深度解读。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135959532","title":"Decoy Therapeutics与Quantori达成战略合作 部署谷歌云原生AI驱动多肽设计与分子模拟平台","url":"https://stock-news.laohu8.com/highlight/detail?id=1135959532","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135959532?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:33","pubTimestamp":1773232399,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics Inc宣布与Quantori建立战略合作伙伴关系，双方将共同部署基于谷歌云原生技术的集成式人工智能驱动多肽设计与分子模拟平台。该合作旨在通过先进的计算生物学技术加速创新疗法的开发进程。此次合作将整合Decoy Therapeutics在生物医药领域的专业优势与Quantori在人工智能和云计算方面的技术积累，打造高效协同的药物研发解决方案。这一战略部署标志着双方在AI驱动药物研发领域迈出关键一步，有望为复杂疾病治疗带来突破性进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146669991","title":"Decoy Therapeutics参与虚拟投资者会议“这意味着什么”环节，重点介绍近期宣布的全球准入承诺协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1146669991","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146669991?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:03","pubTimestamp":1770213795,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics Inc（简称：Decoy Therapeutics）近日参与了虚拟投资者会议“这意味着什么”环节，重点展示了公司最新宣布的全球准入承诺协议。该环节旨在深入解读这一重要协议对公司的战略意义及潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601820407","title":"Salarius Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.94%报0.567美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601820407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601820407?lang=zh_cn&edition=full","pubTime":"2026-01-06 23:33","pubTimestamp":1767713625,"startTime":"0","endTime":"0","summary":"北京时间2026年01月06日23时33分，Salarius Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.94%。Salarius Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Alumis Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Pmgc Holdings Inc.、Cyclerion Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为1801.27%、1449.09%、228.72%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Alumis Inc.，振幅分别为294.74%、161.40%、60.16%。Salarius Pharmaceuticals, Inc.公司简介：Salarius Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于开发针对具有高医疗需求的癌症的有效治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106233346a6faf9f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106233346a6faf9f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DCOY","SLRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.decoytx.com","stockEarnings":[{"period":"1week","weight":0.0288},{"period":"1month","weight":0.1453},{"period":"3month","weight":-0.1874},{"period":"6month","weight":-0.2617},{"period":"1year","weight":-0.9688},{"period":"ytd","weight":-0.2204}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Decoy Therapeutics Inc.是一家于2014年2月26日在特拉华州注册成立的生物技术公司，并且其业务主要发生在马萨诸塞州的波士顿。该公司是一家临床阶段的生物制药公司，专注于为癌症患者开发创新治疗选择。其产品组合包括 seclidemstat，这一主要候选药物目前正在MD安德森癌症中心进行1/2 阶段临床研究，旨在针对骨髓增生异常综合症 (MDS) 和慢性髓单核白血病 (CMML) 等血液系统癌症，特别是为治疗选择有限的患者开发。此外，公司还在推进SP-3164，这是一种口服小分子蛋白降解剂，目前处于新药研究阶段 (IND)。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.032258},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.05363},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.015981},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.073653},{"month":5,"riseRate":0.583333,"avgChangeRate":0.034905},{"month":6,"riseRate":0.5,"avgChangeRate":-0.069768},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.136217},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.111993},{"month":9,"riseRate":0.090909,"avgChangeRate":-0.12638},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.128321},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.062226},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.07199}],"exchange":"NASDAQ","name":"Decoy Therapeutics Inc","nameEN":"Decoy Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Decoy Therapeutics Inc(DCOY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Decoy Therapeutics Inc(DCOY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Decoy Therapeutics Inc,DCOY,Decoy Therapeutics Inc股票,Decoy Therapeutics Inc股票老虎,Decoy Therapeutics Inc股票老虎国际,Decoy Therapeutics Inc行情,Decoy Therapeutics Inc股票行情,Decoy Therapeutics Inc股价,Decoy Therapeutics Inc股市,Decoy Therapeutics Inc股票价格,Decoy Therapeutics Inc股票交易,Decoy Therapeutics Inc股票购买,Decoy Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Decoy Therapeutics Inc(DCOY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Decoy Therapeutics Inc(DCOY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}